EGFR-TKI is a small molecule drug that can act on the receptor tyrosine kinase region in the cells, effectively inhibit tyrosine kinase phosphorylation and downstream signal transduction, and promote cancer cell apoptosis, anti-angiogenesis, anti-differentiation and proliferation, and anti-cell migration. Here, NTRK1 is linked to cancer.